Related Experiment Video

Updated: Jul 2, 2026

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

Assessment and key targets for therapy in the post-myocardial infarction patient with left ventricular dysfunction

James D Flaherty1, James E Udelson, Mihai Gheorghiade

  • 1Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA. j-flaherty2@md.northwestern.edu

The American Journal of Cardiology
|October 3, 2008
PubMed

Insights

This review covers assessing coronary artery disease, myocardium, and conduction system issues in heart attack patients with left ventricular dysfunction. Understanding disease severity is key for effective treatment strategies.

Area of Science:

  • Cardiology
  • Cardiac Pathophysiology
  • Medical Imaging

Background:

  • Post-myocardial infarction (MI) patients with coronary artery disease (CAD) and left ventricular dysfunction (LVD) face challenges like ischemia and adverse remodeling.
  • These conditions impair heart function and increase the risk of electrical instability.
  • The coronary arteries, myocardium, and conduction system are primary targets for therapeutic intervention in these patients.

Purpose of the Study:

  • To review current assessment modalities for key pathophysiologic targets in post-MI patients with LVD.
  • To discuss the impact of systemic factors on cardiac disease severity in this population.

Main Methods:

  • Literature review of current diagnostic and assessment techniques.
  • Analysis of pathophysiologic mechanisms in post-MI LVD.
  • Evaluation of systemic factors influencing cardiac disease.

Main Results:

  • Various imaging and assessment modalities exist for evaluating coronary arteries, myocardium, and conduction system.
  • Disease severity in these targets directly impacts therapeutic program design.
  • Systemic factors play a significant role in modulating cardiac disease severity.

Conclusions:

  • Accurate assessment of coronary arteries, myocardium, and conduction system is crucial for managing post-MI patients with LVD.
  • Understanding the influence of systemic factors is vital for comprehensive patient care.
  • Effective therapeutic strategies depend on a thorough evaluation of these pathophysiologic targets.

More Related Videos

Myocardial Infarction and Functional Outcome Assessment in Pigs12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...